Erratum: A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies.

MLA

Post, Anke, et al. “Erratum: A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies.” Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, vol. 41, no. 10, Sept. 2016, p. 2624. EBSCOhost, https://doi.org/10.1038/npp.2016.78.

APA

Post, A., Smart, T. S., Krikke-Workel, J., Dawson, G. R., Harmer, C. J., Browning, M., Jackson, K., Kakar, R., Mohs, R., Statnick, M., Wafford, K., McCarthy, A., Barth, V., & Witkin, J. M. (2016). Erratum: A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 41(10), 2624. https://doi.org/10.1038/npp.2016.78

Chicago

Post, Anke, Trevor S Smart, Judith Krikke-Workel, Gerard R Dawson, Catherine J Harmer, Michael Browning, Kimberley Jackson, et al. 2016. “Erratum: A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies.” Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 41 (10): 2624. doi:10.1038/npp.2016.78.